Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 13 results for "Biotech Food"

Regeneron, Sanofi rheumatoid arthritis drug wins U.S. approval
Reuters

Regeneron, Sanofi rheumatoid arthritis drug wins U.S. approval

The U.S. Food and Drug Administration approved Regeneron Pharmaceuticals and Sanofi's biotech drug for adults with moderate to severe rheumatoid arthritis, the two companies said on Monday. The drug, sarilumab, which will be sold under the brand name Kevzara, ... Reuters, 1 month ago

25 images for Biotech Food

Business Daily Africa, 6 months ago
Nasdaq, 4 months ago
Financial Buzz, 4 months ago
IDFA, 5 months ago
Today's General Counsel, 5 months ago
Nasdaq, 5 months ago
Forbes.com, 6 months ago
Nasdaq, 5 months ago
Forbes.com, 5 months ago
Nasdaq, 5 months ago
Sify

Google bets on European biotech drugs, backs new fund

LONDON: Google is betting on the potential of European biotech companies to deliver life-changing drugs by investing alongside Swiss company Novartis in a new $300 million fund run by leading life sciences investment firm Medicxi. The move shows Google ...
 Sify1 week ago
Sify

Dow launches new GMO corn after landing China import approval

By Dominique Patton and Hallie Gu BEIJING (Reuters) - Dow Chemical Co secured import approval from China for its next-generation Enlist corn variety and announced it would be commercially available in the United States and Canada next year, but the company ...
 Sify1 week ago

Sensex Opens Flat; Cipla Plunges on Poor Q4 Results

Posted by Equitymaster Stock markets in Asia are lower today despite major oil producers agreeing to extend output cut for an additional nine months at an Opec meeting in Vienna. The Shanghai Composite is off 0.03%, while the Hang Seng is down 0.14%. The ...
 Equitymaster.com1 month ago Share Markets in India Open Flat; Cipla Plunges on Poor Q4 Results  Equitymaster.com1 month ago
Sify

Drug approvals bounce back as R&D labs churn out new winners

By Ben Hirschler LONDON (Reuters) - The number of new drugs approved for sale in United States and Europe has bounced back this year, suggesting a marked slowdown in 2016 was an aberration rather than a sign of flagging research and development productivity.
 Sify1 month ago
catchnews.com

AgriMin to promote GM mustard after environmental clearance

With the environment ministry soon likely to take a decision on whether to allow GM mustard for commercial cultivation, the agriculture ministry has said that it has no problem with the biotech crop once it is released by a competent authority. “We do not ...
 The Financial Chronicle1 month ago Prashant Bhushan questions approval for GM mustard in letter to Anil Dave  catchnews.com1 month ago

Sensex Opens in Green; Realty Sector Up by 2.4%

Posted by Equitymaster Stock markets in Asia are mixed today following the widely-expected results of the first round of presidential elections in France. The Shanghai Composite is off 1.50%, while the Hang Seng is down 0.29%. The Nikkei 225 is trading higher ...
 Equitymaster.com2 months ago

How artificial life spawned a billion dollar industry

Scientists are getting closer to building life from scratch and technology pioneers are taking notice, with record sums moving into a field that could deliver novel drugs, materials, chemicals and even perfumes. Despite ethical and safety concerns, investors ...
 The Financial Chronicle2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less